UT Research Foundation licensee Veru, Inc. announced on April 11, 2022, that their Phase 3 clinical trial of sabizabulin as an oral therapy for hospitalized severe COVID-19 patients at high risk for Acute Respiratory Distress Syndrome (ARDS) and death showed the drug to be safe and effective. The trial was halted early due to the (read more)
Inventions & Patents
UTSI technology may have a far-reaching impact on the future of micro-satellite space travel Over the last few decades, the field of satellite technology has started to shift toward miniaturization. Instead of satellites the size of cars or school buses, researchers are now creating satellites as small as a Rubik’s® Cube to offer a more (read more)
“AUTM’s recognition of Dr. Peter Tsai and Dr. Michael Whitt emphasizes the high-caliber research and technology coming out of the UT System…”, UTRF President Dr. Stacey Patterson.